Traitement par les statines : quid du traitement personnalisé ?

Rev Med Suisse. 2023 Jun 28;19(833):1286. doi: 10.53738/REVMED.2023.19.833.1286.
[Article in French]
No abstract available

Publication types

  • News

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Precision Medicine

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors